| | | | | |
FVRR Fiverr International Ltd. | $9,4300 | -0,53% | $340,45M | $449,98K | |
EMF Templeton Emerging Markets Fund | $22,4600 | +0,04% | $339,61M | $59,73K | |
STRO Sutro Biopharma, Inc. | $20,8000 | +2,77% | $339,08M | $129,48K | |
| $9,0900 | -2,15% | $339,01M | $615,77K | |
JRI NUVEEN REAL ASSET INCOME AND GROWTH FUND | $12,1700 | -0,08% | $338,98M | $191,66K | |
HPF John Hancock Preferred Income Fund II | $15,4600 | -0,71% | $338,61M | $38,39K | |
ABEO Abeona Therapeutics Inc. Common Stock | $5,9750 | +2,14% | $338,52M | $687,20K | |
OPRT Oportun Financial Corporation Common Stock | $7,1350 | -2,93% | $338,46M | $218,42K | |
AGCC Agencia Comercial Spirits Ltd Class A Ordinary Shares | $14,8250 | +1,13% | $338,37M | $4,12K | |
CAII Collective Acquisition Corp. II Class A Ordinary Shares | $9,9950 | +0,05% | $338,30M | $313,00 | |
| $3,9700 | +0,00% | $337,86M | $847,19K | |
AACI Armada Acquisition Corp. III Class A Ordinary Share | $10,0100 | -0,30% | $337,57M | $553,00 | |
FSBW FS Bancorp, Inc. Common Stock | $42,6700 | +0,88% | $336,89M | $17,45K | |
CUVL Clinuvel Pharmaceuticals Limited American Depositary Shares | $6,2550 | +5,13% | $336,85M | $44,90K | |
PTOR Praetorian Acquisition Corp. Class A Ordinary Shares | $9,9850 | -0,10% | $336,85M | $15,04K | |
